Table 5. Effect of TUNA versus TURP for BPH on sexual function.
| Authors and study year | Study design | Follow-up (months) | Patient (n) |
Validated questionnaire | ↓ EF (%) |
↑ EF (%) |
EjD (%) |
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Laser | TURP | Laser | TURP | Laser | TURP | Laser | TURP | ||||
| Bruskewitz et al. 1998 30 | RCT | 12 | 65 | 56 | No | 0 | 12.7 | – | – | 13 | 54 |
| Cimentepe et al. 2003 31 | RCT | 18 | 26 | 33 | IIEF | 0 | 12 | – | – | 0 | 48.5 |
| Hill et al. 2004 32 | RCT | 60 | 65 | 56 | No | 3.1 | 21.4 | – | – | 0 | 41.1 |
| Arai et al. 2000 24 | Cohort* | 3 | 42 | 55 | SMUSFQ | 20 | 26.5 | 7.9 | 20.4 | 9.2 | 15 |
| Weighted mean | 23.3 ± 25.3 | 198 (total) | 200 (total) | 5.8 ± 9.6 | 18.2 ± 7.1 | 7.9 | 20.4 | 5.6 ± 6.6 | 39.7 ± 17.3 | ||
Abbreviations: BPH, benign prostate hyperplasia; EF, erectile function; EjD, ejaculatory dysfunction; RCT, randomized control trial; SMUSFQ, Sapporo Medical University Sexual Function Questionnaire; TUNA, transurethral needle ablation; TURP, transurethral resection of the prostate; –, not reported; *, cohort with multiple groups.